A citation-based method for searching scientific literature

Yuri E Nikiforov. Endocr Pathol 2002
Times Cited: 307



Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong, Steven I Sherman, Johannes W A Smit, John Chung, Christian Kappeler, Carol Peña, István Molnár, Martin J Schlumberger. Lancet 2014
Times Cited: 858




List of shared articles



Times cited

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
1

Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions.
Mariantonia Nacchio, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Elena Vigliar, Tommaso Porcelli, Cristina Luongo, Antonino Iaccarino, Fabio Pagni, Domenico Salvatore,[...]. Expert Rev Endocrinol Metab 2022
0

Systemic Therapy in Thyroid Cancer.
Amit Kumar Agrawal, Vanita Noronha, Vijay Patil, Nandini Menon, Akhil Kapoor, Anuradha Chougule, Pratik Chandrani, Kumar Prabhash. Indian J Surg Oncol 2022
0


Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects.
Ivana Puliafito, Francesca Esposito, Angela Prestifilippo, Stefania Marchisotta, Dorotea Sciacca, Maria Paola Vitale, Dario Giuffrida. Front Endocrinol (Lausanne) 2022
0

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
15

Lenvatinib-Induced Acute Pancreatitis in a Patient with Metastatic Thyroid Cancer: A Case Report.
Hong Jun Kim, Jae Joon Han, Chi Hoon Maeng, Sun Kyung Baek. Int J Gen Med 2020
1

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Giorgia Acquaviva, Michela Visani, Andrea Repaci, Kerry J Rhoden, Dario de Biase, Annalisa Pession, Tallini Giovanni. Histopathology 2018
63

Key signaling pathways in thyroid cancer.
Miguel A Zaballos, Pilar Santisteban. J Endocrinol 2017
62

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
168

Targeted therapies in thyroid cancer: an extensive review of the literature.
Athanasios Bikas, Shivangi Vachhani, Kirk Jensen, Vasyl Vasko, Kenneth D Burman. Expert Rev Clin Pharmacol 2016
21



Advances in thyroid cancer treatment: latest evidence and clinical potential.
T Alonso-Gordoa, J J Díez, M Durán, Enrique Grande. Ther Adv Med Oncol 2015
34

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
974